An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

scientific article published on 27 July 2020

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PPAT.1008795
P698PubMed publication ID32716975

P50authorSita AwasthiQ88784691
Gary H CohenQ88784699
Harvey M. FriedmanQ89912954
Lauren M. HookQ42230866
Norbert PardiQ88256458
Drew WeissmanQ88608402
P2093author name stringKevin P Egan
Alexis Naughton
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue7
P921main subjectHerpes simplex virus type 1Q655331
genital herpesQ7476596
RNA vaccineQ85795487
Human herpesvirus 2Q18965147
P304page(s)e1008795
P577publication date2020-07-27
P1433published inPLOS PathogensQ283209
P1476titleAn HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
P478volume16